Novo Nordisk has asked the FDA to dam production of compounded copies of copyright, arguing that it’s much too difficult to do safely. It’s the latest escalation within a brewing war concerning pharmaceutical providers and compounders.Now, as lawmakers are closing in on illegal THC cartridges, the marketplace is receding into the shadows of the